GenePaws.AI is the first platform to combine pet DNA sequencing with a fully transparent, COA-verified supplement line. We exist because pet health deserves the same precision medicine revolution that human health is experiencing.
Six distinct editorial angles for covering GenePaws.AI β from pet tech to consumer safety to veterinary medicine.
GenePaws.AI is the first platform to combine pet genomic sequencing with a proprietary liquid supplement line that is triggered by the pet's actual DNA results β not guesswork. Every supplement recommendation is generated by AI, reviewed by a board-certified veterinary nutritionist (DACVN), and traceable to a published scientific study.

GenePaws.AI β Company Fact Sheet
Company Name
GenePaws.AI
Parent Company
Gmax Central, LLC (also operates Cleverpetz)
Headquarters
500 Westover Dr #92909, Sanford, NC 27330
Founded
2024
Funding Stage
Pre-Seed / Bootstrapped (Seed round in preparation)
Industry
Pet Health Technology, Animal Dietary Supplements, Genomics
Business Model
DTC e-commerce + DNA testing kit + AI supplement protocol platform
Product Count
35 proprietary liquid supplement SKUs (Phase 1) + 6 DNA kits across 6 species
Supplement Format
Liquid drops (all products) β 85β98% bioavailability vs. 5β18% for capsules
DNA Panel
247,000+ SNP markers β canine flagship; 200,000+ feline; equine, reptile, avian, aquatic
Veterinary Oversight
All protocols reviewed by DACVN-credentialed veterinarians
Certifications (Target)
NASC Quality Seal, Non-GMO, Leaping Bunny, Certified Vegan
Key Differentiator
DNA-triggered supplement protocol + QR-linked COA verification on every bottle
Website
genepaws.ai
Press Contact
All assets are available in the press kit PDF. Contact [email protected] for individual file requests.
Brand Color Palette
Navy
#1e3a5f
Pantone 289 C
Primary brand color β headings, nav, CTAs
Sky Blue
#0ea5e9
Pantone 299 C
Accent β links, badges, highlights
Cyan
#22d3ee
Pantone 305 C
Secondary accent β gradient, DNA elements
White
#ffffff
White
Background, text on dark
Slate
#f8fafc
Pantone Cool Gray 1 C
Section backgrounds
Charcoal
#1e293b
Pantone 432 C
Body text, dark sections
Primary Logo (PNG)
Full-color GenePaws.AI logo on white background
PNGLogo on Dark (PNG)
White logo for dark backgrounds
PNGBrand Color Palette
Navy (#1e3a5f), Sky Blue (#0ea5e9), White (#ffffff), Slate (#f8fafc)
PDF / ASETypography Guide
Space Grotesk (headings), Inter (body)
PDFProduct Photography
High-resolution product shots on white and lifestyle backgrounds
JPG / PNGLifestyle Photography
Dogs, cats, horses, and owners with GenePaws.AI products
JPGDNA & Science Illustrations
Custom infographics explaining the DNA-to-supplement process
PNG / SVGBrand Guidelines PDF
Complete brand usage guide including do's and don'ts
PDFFebruary 2026
EMBARGOED β available upon requestGenePaws.AI Launches First DNA-Triggered Pet Supplement Platform with QR-Verified COA on Every Bottle
GenePaws.AI today announced the public launch of its DNA-triggered pet supplement platform, combining 247,000-marker genomic sequencing with a fully transparent supplement line verified by third-party Certificates of Analysis.
Q2 2026 (Planned)
UPCOMINGGenePaws.AI Announces Seed Round and Expansion to Wholesale Retail Network
GenePaws.AI plans to announce its seed funding round and the launch of its wholesale program targeting independent pet retailers across the United States.
Q3 2026 (Planned)
UPCOMINGGenePaws.AI Receives NASC Quality Seal β First DNA-Supplement Platform to Achieve Certification
GenePaws.AI is pursuing NASC Quality Seal certification, which would make it the first DNA-triggered supplement platform to achieve this industry standard.
Standard description for use in articles, press releases, and media coverage.
GenePaws.AI is the first DNA-triggered pet supplement platform, combining 247,000-marker genomic sequencing with a fully transparent supplement line verified by third-party Certificates of Analysis (COA). Every supplement protocol is generated by AI and reviewed by a board-certified veterinary nutritionist (DACVN) before delivery. All products are formulated as liquid drops for maximum bioavailability and carry a QR code linking to the live COA for that specific batch. GenePaws.AI is operated by Gmax Central, LLC, headquartered in Sanford, NC. For more information, visit genepaws.ai.
The Science Behind GenePaws.AI
GenePaws.AI's SNP microarray analyzes 247,000+ genetic markers in dogs and 200,000+ in cats β identifying breed composition, hereditary health risks, drug sensitivities, and physical trait predictions. The AI engine maps these results to our 35-product proprietary supplement catalog and generates a personalized protocol reviewed by a licensed veterinarian.
247K+
Genetic Markers
6
Species Covered
35
Proprietary SKUs
100%
Vet Review

General Press Inquiries
Press Team
[email protected]Story pitches, interview requests, product samples, general media inquiries
β± Response within 4 business hours
Investor & Business Media
Cedric Leyniers, Founder & CEO
[email protected]Investor relations, business strategy, funding announcements
β± Response within 1 business day
Science & Veterinary Media
Science Team
[email protected]Technical questions about DNA methodology, supplement formulation, COA verification
β± Response within 2 business days
Enter your details below and we'll send you the full press kit PDF β including brand assets, founder bios, product catalog, and company fact sheet β instantly.